Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing childhood atopic dermatitis.

Alexander K C Leung1, Kirk A Barber

  • 1Department of Pediatrics, University of Calgary, Alberta, Canada.

Advances in Therapy
|September 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and Correlation Analysis of Neuropeptide Family Members in the Peripheral Blood of Patients with COVID-19.

Current pediatric reviews·2026
Same author

A Narrative Review of Dietary Interventions and Supplementation for the Prevention and Treatment of Atopic Dermatitis.

Current pediatric reviews·2026
Same author

Correction: The future of severe acute respiratory syndrome-coronavirus and coronavirus disease.

World journal of pediatrics : WJP·2026
Same author

Infectious associations in childhood Kawasaki Disease.

Current pediatric reviews·2026
Same author

The EAT Algorithm: A Visual Tool to De-escalate Food Avoidance Anxiety in Parents.

Current pediatric reviews·2026
Same author

The future of severe acute respiratory syndrome-cornavirus and coronavirus disease.

World journal of pediatrics : WJP·2026

Atopic dermatitis treatment is evolving. Topical immunomodulators offer a safe alternative to corticosteroids for managing this common childhood skin condition.

Area of Science:

  • Dermatology and Immunology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition affecting up to 20% of school-aged children.
  • It significantly impacts patients' quality of life.
  • Current management includes trigger avoidance, skin care, and corticosteroids for flares.

Purpose of the Study:

  • To evaluate topical immunomodulators as an alternative to corticosteroids for atopic dermatitis.
  • To assess the safety and efficacy of these new agents, particularly in pediatric populations.

Main Methods:

  • Review of existing literature on atopic dermatitis treatments.
  • Comparison of safety and efficacy profiles of corticosteroids versus topical immunomodulators (tacrolimus, pimecrolimus).

Main Results:

  • Corticosteroids have short-term safety but potential long-term adverse effects.

Related Experiment Videos

  • Topical immunomodulators demonstrate beneficial and safe profiles in both adults and children.

    • Conclusions:

    • Topical immunomodulators represent a significant advancement in atopic dermatitis management.
    • These agents offer a safe and effective alternative to chronic corticosteroid use, especially for children.